Spruce Biosciences, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Spruce Biosciences, Inc. (SPRB) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$14.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-09
- Spruce Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$14.60M, a 180.22% decline from fiscal 2024.
- Spruce Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $18.20M, a 8.33% increase from fiscal 2023.
- Spruce Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $16.80M, a 1.18% decline from fiscal 2022.
- Spruce Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $17.00M, a 22.30% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | -$14.60M 10-K · filed 2026-03-09 |
| 2024-12-31 | $18.20M 10-K · filed 2026-03-09 |
| 2023-12-31 | $16.80M 10-K · filed 2025-04-15 |
| 2022-12-31 | $17.00M 10-K · filed 2024-03-18 |
| 2021-12-31 | $13.90M 10-K · filed 2023-03-16 |
| 2020-12-31 | $12.20M 10-K · filed 2022-03-14 |
| 2019-12-31 | $3.00M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |